跳至主要内容
临床试验/NL-OMON40486
NL-OMON40486已完成不适用

Adverse effects of radioiodine treatment on salivary glands in differentiated thyroid carcinoma patients - Radioiodine and salivary glands

niversitair Medisch Centrum Groningen0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age at diagnosis is at least 18 years
  • 2. The patient is awaiting radioiodine ablation therapy following DTC diagnosis, or is in follow-up for DTC and awaiting radioiodine therapy for persistent or recurrent disease
  • 3. The subject gives written informed consent for study participation

排除标准

  • 1. A history of Sjögrens syndrome or other salivary gland disease affecting salivary gland function
  • 2. Oral ulceration
  • 3. Patient is mentally incapacitated
  • 4. Patient receives recombinant human TSH (rhTSH) prior to I131 treatment

研究者

相似试验